共 300 条
[1]
Arinami T(1997)A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia Hum Mol Genet 6 577-582
[2]
Gao M(1999)Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers Mol Psychiatry 4 290-296
[3]
Hamaguchi H(1997)D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele Pharmacogenetics 7 479-484
[4]
Toru M(1996)Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 243-250
[5]
Jonsson EG(2000)Recruiting women into a smoking cessation program: who might quit? Women 31 41-58
[6]
Nothen MM(1988)Optimum cutoff points for biochemical validation of smoking status Am J Public Health 78 574-575
[7]
Grunhage F(2001)Echocardiographic examination of women previously treated with fenfluramine: long-term follow-up of a randomized, double-blind, placebo-controlled trial. Arch 161. 161 1429-36, 1429-36.
[8]
Farde L(1981)Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users Clin Pharmacol Ther 30 201-209
[9]
Nakashima Y(1988)Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure Am J Public Health 78 696-698
[10]
Propping P(2005)Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women Pharmacogenet Genomics 15 393-398